• Join
  • Login
  • Contact

Search abstracts

The lfcs consortium: in vitro dispersion tests are an effective first screen during lipid-based formulation development and evaluation

  • In: Posters D - Formulation Design and Pharmaceutical Technology
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Poster
  • Poster code: PD-067
  • By: POUTON, Colin (Monash University, Monash Institute of Pharmaceutical Sciences, Parkville, Australia)
  • Co-author(s): Williams, Hywel (Monash University, Parkville, Australia)
    Anby, Mette (Monash University, Parkville, Australia)
    Mcevoy, Claire (Monash University, Parkville, Australia)
    Thomas, Nicky (University of Copenhagen, Copenhagen, Denmark)
    Calderone, Marilyn (Sanofi R&D, Montpellier, France)
    Igonin, Annabel (Capsugel, Illkirch, France)
    Vertommen, Jan (Capsugel, Illkirch, France)
    Blundell, Ross (Sanofi R&D, Montpellier, France)
    Benameur, Hassan (Capsugel, Illkirch, France)
    Mullertz, Anette (University of Copenhagen, Copenhagen, Denmark)
    Porter, Chris (Monash University, Parkville, Australia)
  • Abstract:

    I. Background: The LFCS Consortium looks to establish standardized in vitro performance tests for lipid-based formulations (LBF).
    II. Aims: Here we evaluate the performance of four LBFs containing danazol (DAN), fenofibrate (FFB), tolfenamic acid (TA) or cinnarizine (CIN) on dispersion using different test conditions.
    III. Methods: Dispersion..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses